DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 151 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $731 | +223.5% | 57,498 | +257.8% | 0.01% | +250.0% |
| Q2 2023 | $226 | -84.7% | 16,072 | -82.1% | 0.00% | -90.5% |
| Q4 2022 | $1,474 | -99.9% | 89,970 | +2.6% | 0.02% | +16.7% |
| Q3 2022 | $1,622,000 | +699.0% | 87,728 | +466.9% | 0.02% | +800.0% |
| Q2 2022 | $203,000 | -91.0% | 15,474 | -93.6% | 0.00% | -87.5% |
| Q1 2022 | $2,252,000 | +238.1% | 242,998 | +1138.0% | 0.02% | +300.0% |
| Q3 2021 | $666,000 | +206.9% | 19,628 | +414.5% | 0.00% | 0.0% |
| Q4 2020 | $217,000 | -55.6% | 3,815 | -73.5% | 0.00% | -82.6% |
| Q3 2019 | $489,000 | – | 14,415 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $15,385,743 | 19.76% |
| Redmile Group, LLC | 4,475,384 | $56,926,884 | 2.71% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,897,606 | $87,737,548 | 1.93% |
| Parkman Healthcare Partners LLC | 597,403 | $7,598,966 | 1.39% |
| Ghost Tree Capital, LLC | 325,000 | $4,134,000 | 1.36% |
| BRAIDWELL LP | 3,336,221 | $42,436,731 | 1.34% |
| AlphaCentric Advisors LLC | 132,000 | $1,679,040 | 0.95% |
| ARMISTICE CAPITAL, LLC | 4,612,000 | $58,664,640 | 0.90% |
| Sunesis Advisors, LLC | 96,299 | $1,224,923 | 0.87% |
| EcoR1 Capital, LLC | 993,000 | $12,630,960 | 0.43% |